Total Payments
$2,510
2024 Payments
$105.63
Companies
33
Transactions
173
Medicare Patients
437
Medicare Billing
$37,994
Payment Breakdown by Category
Food & Beverage$2,368 (94.3%)
Education$142.27 (5.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,368 | 166 | 94.3% |
| Education | $142.27 | 7 | 5.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $444.83 | 23 | $0 (2022) |
| Astellas Pharma US Inc | $293.15 | 18 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $265.01 | 17 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $226.18 | 23 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $183.74 | 10 | $0 (2019) |
| Pharmacyclics LLC, An AbbVie Company | $155.83 | 8 | $0 (2017) |
| PFIZER INC. | $144.43 | 15 | $0 (2017) |
| Daiichi Sankyo Inc. | $74.71 | 5 | $0 (2017) |
| Janssen Biotech, Inc. | $72.60 | 10 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $70.85 | 6 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $105.63 | 4 | Ipsen Biopharmaceuticals, Inc ($50.48) |
| 2023 | $42.38 | 2 | GENZYME CORPORATION ($25.47) |
| 2022 | $17.06 | 1 | Genentech USA, Inc. ($17.06) |
| 2019 | $14.68 | 1 | Merck Sharp & Dohme Corporation ($14.68) |
| 2018 | $68.14 | 5 | Astellas Pharma US Inc ($49.63) |
| 2017 | $2,262 | 160 | Genentech USA, Inc. ($427.77) |
All Payment Transactions
173 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: Oncology | ||||||
| 10/02/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $30.73 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/01/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: Oncology | ||||||
| 04/04/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Oncology | ||||||
| 08/18/2023 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Oncology | ||||||
| 05/02/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: ONCOLOGY | ||||||
| 08/11/2022 | Genentech USA, Inc. | GAZYVA (Biological), VENCLEXTA, POLIVY | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: BioOncology | ||||||
| 10/23/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: ONCOLOGY | ||||||
| 03/09/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: ONCOLOGY | ||||||
| 01/19/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: ONCOLOGY | ||||||
| 01/10/2018 | Sysmex Inostics Inc | — | Food and Beverage | Cash or cash equivalent | $8.08 | General |
| 01/09/2018 | Sysmex Inostics Inc | — | Food and Beverage | Cash or cash equivalent | $10.43 | General |
| 01/02/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: ONCOLOGY | ||||||
| 12/21/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Oncology | ||||||
| 12/19/2017 | Genentech USA, Inc. | Erivedge (Biological), COTELLIC | Food and Beverage | In-kind items and services | $9.63 | General |
| Category: BioOncology | ||||||
| 12/14/2017 | Genentech USA, Inc. | Avastin (Biological), Alecensa | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: BioOncology | ||||||
| 12/13/2017 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $8.71 | General |
| Category: Oncology | ||||||
| 12/07/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2017 | E.R. Squibb & Sons, L.L.C. | SPRYCEL (Drug) | Food and Beverage | Cash or cash equivalent | $107.69 | General |
| Category: Oncology | ||||||
| 12/06/2017 | Novartis Pharmaceuticals Corporation | VOTRIENT (Drug) | Food and Beverage | In-kind items and services | $9.99 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2017 | PFIZER INC. | SUTENT (Drug) | Education | In-kind items and services | $11.40 | General |
| Category: ONCOLOGY;RESPIRATORY | ||||||
| 12/05/2017 | PFIZER INC. | SUTENT (Drug), XALKORI, INLYTA | Food and Beverage | In-kind items and services | $10.13 | General |
| Category: ONCOLOGY;RESPIRATORY | ||||||
| 11/30/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $9.24 | General |
| Category: Oncology | ||||||
| 11/29/2017 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $11.98 | General |
| 11/29/2017 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $7.23 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 119 | 6,628 | $46,990 | $11,862 |
| 2022 | 4 | 74 | 1,048 | $34,710 | $9,763 |
| 2021 | 3 | 52 | 55 | $9,930 | $3,403 |
| 2020 | 9 | 192 | 1,091 | $45,243 | $12,966 |
Total Patients
437
Total Services
8,822
Medicare Billing
$37,994
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 12 | 780 | $18,720 | $4,657 | 24.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 21 | 24 | $9,480 | $2,391 | 25.2% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 11 | 5,610 | $11,220 | $2,277 | 20.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 20 | $3,000 | $1,372 | 45.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 11 | 11 | $1,650 | $551.76 | 33.4% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 12 | 25 | $1,250 | $302.29 | 24.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 28 | $1,540 | $298.35 | 19.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 11 | 130 | $130.00 | $12.68 | 9.8% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2022 | 15 | 980 | $23,520 | $6,376 | 27.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 16 | 18 | $7,110 | $1,969 | 27.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 14 | $2,100 | $1,009 | 48.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 29 | 36 | $1,980 | $409.25 | 20.7% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 14 | 15 | $5,925 | $1,768 | 29.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 19 | $2,850 | $1,397 | 49.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 20 | 21 | $1,155 | $238.98 | 20.7% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2020 | 15 | 720 | $20,160 | $5,801 | 28.8% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 28 | 31 | $12,245 | $3,261 | 26.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 29 | 32 | $4,800 | $1,685 | 35.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2020 | 20 | 20 | $3,000 | $1,045 | 34.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 42 | 43 | $2,365 | $418.18 | 17.7% |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2020 | 21 | 31 | $1,550 | $403.57 | 26.0% |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | Office | 2020 | 11 | 13 | $845.00 | $318.83 | 37.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2020 | 15 | 190 | $190.00 | $18.52 | 9.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2020 | 11 | 11 | $88.00 | $14.96 | 17.0% |
About Dr. Maurice Schwarz, M.D
Dr. Maurice Schwarz, M.D is a Hematology & Oncology healthcare provider based in Mechanicsville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922061126.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maurice Schwarz, M.D has received a total of $2,510 in payments from pharmaceutical and medical device companies, with $105.63 received in 2024. These payments were reported across 173 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($2,368).
As a Medicare-enrolled provider, Schwarz has provided services to 437 Medicare beneficiaries, totaling 8,822 services with total Medicare billing of $37,994. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Mechanicsville, VA
- Active Since 04/10/2006
- Last Updated 05/21/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1922061126
Products in Payments
- Xtandi (Drug) $243.52
- KEYTRUDA (Biological) $183.74
- Avastin (Biological) $170.65
- Imbruvica (Drug) $155.83
- SPRYCEL (Drug) $119.21
- AFINITOR (Drug) $100.16
- XTANDI (Drug) $84.42
- OPDIVO (Biological) $83.59
- SUTENT (Drug) $75.08
- INJECTAFER (Drug) $74.71
- XARELTO (Drug) $70.85
- Onivyde (Drug) $50.48
- EMPLICITI (Biological) $49.13
- FASLODEX (Drug) $43.52
- ZYTIGA (Drug) $41.31
- Venclexta (Drug) $38.96
- Perjeta (Biological) $33.48
- BOSULIF (Drug) $32.60
- IMBRUVICA (Drug) $31.29
- Cabometyx (Drug) $30.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Mechanicsville
Maura Hagan, M.d, M.D
Hematology & Oncology — Payments: $7,119
Hematology & Oncology $7,119
Dr. Aisha Zaidi, Md, MD
Hematology & Oncology — Payments: $3,983
Hematology & Oncology $3,983
Seaborn Wade, M.d, M.D
Hematology & Oncology — Payments: $3,820
Hematology & Oncology $3,820
Angela Vanlandingham, M.d, M.D
Hematology & Oncology — Payments: $3,618
Hematology & Oncology $3,618